UNSPSC 51101634: Antienite

This classification denotes an antihelminthic agent with the molecular formula C9H8N2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 50Z1JVP72H, chemically known as imidazo(2,1-b)thiazole, 5,6-dihydro-6-(2-thienyl)-, ( -)- but generally known as antienite, which bears US NIH Compound Identifier 170351. European Medicines Agency schedules Antienite in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05529MIG. The term ANTIENITE is an International Non-Proprietary Name.

UNSPSC 51101634 Antienite is a Commodity code that in recent state and local solicitations covers naloxone, drug deactivation systems, medical and first aid supplies, and generic pharmaceuticals and over-the-counter products procured by health departments, fire departments, and state pharmacy benefit programs. The scope spans both emergency-response medical consumables (respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, bandaging materials, oxygen delivery systems) and pharmaceutical supply chain management, including direct-to-manufacturer prescription programs and bulk generic drug procurement. Issuing bodies include county health departments, municipal fire departments, state health and human services agencies, and cooperative purchasing alliances serving multiple jurisdictions. The Seminole County, Florida procurement of naloxone and drug deactivation systems, the City of Tampa Fire Department's medical and first aid supplies bid, the Minnesota Multistate Cooperative Purchasing Alliance's generic pharmaceuticals RFP, and the Texas Health and Human Services Commission's direct-to-manufacturer prescription initiative represent the range of work currently being solicited under this code.

Recent activity appears concentrated in Florida, Texas, and Minnesota, with cooperative purchasing vehicles playing a significant role. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2026. The City of Tampa Purchasing Department solicited sealed bids for medical and first aid supplies for the Tampa Fire Department Rescue Division (Bid 26-P-00145) due March 13, 2026, with an estimated contract value of $700,000.00 and a designated small local business enterprise set-aside with a 5 percent bid discount. The Minnesota Department of Administration issued RFP S1070000015802 through MMCAP for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, with proposals due March 26, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather market intelligence on direct-to-manufacturer prescription fulfillment capabilities for a future formal procurement. Cooperative purchasing arrangements, state-level health agency participation, and municipal emergency-response procurement form the dominant activity pattern under this code.